Search details
1.
Rivaroxaban vs Dalteparin in Cancer-Associated Thromboembolism: A Randomized Trial.
Chest
; 161(3): 781-790, 2022 03.
Article
in English
| MEDLINE | ID: mdl-34627853
2.
Postthrombotic syndrome and quality of life after deep vein thrombosis in patients treated with edoxaban versus warfarin.
Res Pract Thromb Haemost
; 6(5): e12748, 2022 Jul.
Article
in English
| MEDLINE | ID: mdl-35992565
3.
Quality of life in patients with pulmonary embolism treated with edoxaban versus warfarin.
Res Pract Thromb Haemost
; 5(5): e12566, 2021 Jul.
Article
in English
| MEDLINE | ID: mdl-34278193
4.
Long-term risk of postthrombotic syndrome after symptomatic distal deep vein thrombosis: The CACTUS-PTS study.
J Thromb Haemost
; 18(4): 857-864, 2020 04.
Article
in English
| MEDLINE | ID: mdl-31899848
5.
Comparative study on risk factors and early outcome of symptomatic distal versus proximal deep vein thrombosis: results from the OPTIMEV study.
Thromb Haemost
; 102(3): 493-500, 2009 Sep.
Article
in English
| MEDLINE | ID: mdl-19718469
6.
Anticoagulant therapy for symptomatic calf deep vein thrombosis (CACTUS): a randomised, double-blind, placebo-controlled trial.
Lancet Haematol
; 3(12): e556-e562, 2016 Dec.
Article
in English
| MEDLINE | ID: mdl-27836513
7.
Predictive factors for concurrent deep-vein thrombosis and symptomatic venous thromboembolic recurrence in case of superficial venous thrombosis. The OPTIMEV study.
Thromb Haemost
; 105(1): 31-9, 2011 Jan.
Article
in English
| MEDLINE | ID: mdl-20886192
8.
Using a "non uniform pulse sequence" can improve selective coagulation with a Nd:YAG laser (1.06 microm) thanks to Met-hemoglobin absorption: a clinical study on blue leg veins.
Lasers Surg Med
; 32(2): 160-70, 2003.
Article
in English
| MEDLINE | ID: mdl-12561051
Results
1 -
8
de 8
1
Next >
>>